-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN
-
-
-
-
-
-
-
Geron surges after winning first US FDA approval for blood disorder drug
-
-
-
-
-
-
-
CG Oncology(CGON) Announces Publication of Final Results from CORE-001 Study
-
-
-
-
-
-
-
Madrigal Pharma (MDGL) Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra
-
-
-
-
-
-
-
Ventyx Biosciences (VTYX) Reports Positive Preclinical Data for VTX3232
-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Presents Positive Data For Pitolisant In The Treatment Of Excessive Daytime Sleepiness And Fatigue In Myotonic Dystrophy Type 1
-
-
-
-
-
-
-
Medicinova (MNOV) Receives Notice of Allowance for New Patent Covering MN-166
-
67,342 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.